Novo Integrated Sciences, Inc.

Novo Integrated Sciences, Inc. engages in the provision of medical services. The firm offers specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology, and dental services. Its multi-disciplinary healthcare services and protocols are directed at assessment, treatment, management, rehabilitation, and prevention through its clinics, affiliate clinics, retirement homes, and long-term facilities. The firm operates through the following business segments: healthcare services, and product manufacturing and development. The company was founded by Michael H. Rouse on November 27, 2000 and is headquartered in Bellevue, WA.

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Novo Integrated Sciences, Inc. engages in the provision of medical services. The firm offers specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology, and dental services. Its multi-disciplinary healthcare services and protocols are directed at assessment, treatment, management, rehabilitation, and prevention through its clinics, affiliate clinics, retirement homes, and long-term facilities. The firm operates through the Healthcare Services and Product Sales segments. The company was founded by Michael H. Rouse on November 27, 2000 and is headquartered in Bellevue, WA.

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Advised Receipt of Proceeds of RC Consulting Promissory Note Expected in 3-5 Business Days.

Novo Integrated Sciences Advised Receipt of Proceeds of RC Consulting Promissory Note Expected in 3-5 Business Days

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Announces Issuance of Underlying One Billion Dollar Gold Backed Bond.

Novo Integrated Sciences Announces Issuance of Underlying One Billion Dollar Gold Backed Bond

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences' Board of Directors Approves $5 Million Stock Repurchase Program.

Novo Integrated Sciences' Board of Directors Approves $5 Million Stock Repurchase Program

T2 Biosystems

Hub Cyber Security Ltd

Penny stocks are highly popular among day and swing traders because of their low prices and volatility. Most of these stocks are usually bad long-term investments because of their unprofitability, especially in a high-interest rates environment.

Top 3 penny stocks to day trade: HUBC, TTOO, NVOS

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Provides Update on Certain Current Events.

Novo Integrated Sciences Provides Update on Certain Current Events

Grab Holdings Ltd

Petco Health and Wellness

Penny stocks refer to stocks that trade for less than $5 per share. They are typically small companies that trade over-the-counter or on the OTC.

Penny Stocks To Buy? 4 To Watch Right Now

Novo Integrated Sciences (NASDAQ: NVOS) stock price surged by more than 86% in the pre-market session to a high of $0.38, the highest level since September 18th. It has surged by more than 92% from the lowest level this month, giving it a market cap of over $31 million.

NVOS stock price is surging but Novo Integrated is still risky

Novo Integrated Sciences Inc. NVOS shares more than doubled in the extended session Thursday after the tiny healthcare company said it or entered a $1 billion funding agreement for the next 15 years. Novo Integrated shares soared as much as 155% after hours, following a 15.4% decline to close at 20 cents, giving the company a market capitalization of $31.8 million at the end of the trading day.

Novo Integrated stock more than doubles after hours on $1 billion collateral agreement

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Signs Master Collateral Transfer Agreement. One Billion Dollar Collateral Transfer through Blacksheep Trust.

Novo Integrated Sciences Signs Master Collateral Transfer Agreement

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences' IoNovo for Kids Granted Registration Number and Regulatory Approval by Turkey's Ministry of Health.

Novo Integrated Sciences' IoNovo for Kids Granted Registration Number and Regulatory Approval by Turkey's Ministry of Health

Aurora Cannabis

Asensus Surgical

Better Home & Finance Holding Co

Inpixon

Nektar Therapeutics

Nemaura Medical

Founder SPAC

Senseonics Holdings

Synaptogenix

Let's be honest – penny stocks priced at less than a buck hold an irresistible appeal. Even a small investment could potentially lead to insane returns.

Best Penny Stocks To Buy Now? 10 Under $1 To Watch

Penny stocks priced under $1 per share have attracted a dedicated following among traders seeking massive returns. While penny stocks are inherently high-risk investments, the potential reward with these low-priced shares is exponentially higher compared to traditional blue chip stocks.

Best Penny Stocks To Buy Now? 7 Under $1 To Watch

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Provides Update on Potential Share Repurchase Program.

Novo Integrated Sciences Provides Update on Potential Share Repurchase Program

Penny stocks, typically priced below $5, have become a popular choice for day traders due to their potential for rapid gains. These stocks can offer market-beating returns in a short period, making them attractive for those looking for quick profits.

Best Penny Stocks To Buy Now? 3 Under $1 To Watch

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today announced the Company received an Underwriting Clearance Notice from RC Consulting Group LLC informing Novo that the underwriting analysis process and compliance review for the transaction between Novo and RC Consulting LLC in favor of SCP Tourbillion Monaco (the “Buyer”), dated April 26, 2023, has been affirmed and approved for completion resulting in the recommendation to proceed w.

Novo Integrated Sciences Receives Underwriter Clearance Notice for $70,000,000 Coupon

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today announced that Acenzia, a nutraceutical manufacturer and a Canadian subsidiary of Novo, has been invited to join the Team Canada Trade Mission to India, led by the Honorable Mary Ng, Canada's Minister of International Trade, Export Promotion, Small Business and Economic Development. For Acenzia, being selected to be a member of this Canada-India Trade Mission is an honor and validate.

Acenzia Selected to join Team Canada Trade Mission to India

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today announced that its IoNovo Iodine product has been granted a registration number and received regulatory approval by Turkey's Ministry of Health as a dietary supplement determined to be safe, effective, of high quality, and eligible for sale in Turkey. For decades, the global medical community has recognized Iodine as an essential micronutrient that assists the thyroid to produce T3 a.

Novo Integrated Sciences' IoNovo Iodine Granted Registration Number and Regulatory Approval by Turkey's Ministry of Health

It's been quite a week for investors in Novo Integrated Sciences (NASDAQ: NVOS ). Shares of NVOS stock traded at less than 7 cents apiece to start last week but surged as high as 23 cents on Wednesday on a number of key business updates.

NVOS Stock Alert: Novo Seeks Approval for a Reverse Stock Split

Novo Integrated Sciences (NASDAQ: NVOS ) stock is rocketing higher on Wednesday after a couple of updates from the healthcare services company. The first bit of news worth noting is the company entering into a joint venture with Farm 7 Group.

Why Is Novo Integrated Sciences (NVOS) Stock Up 67% Today?

Novo Integrated Sciences (NASDAQ: NVOS ) stock is skyrocketing on Tuesday, enlivening a down session on Wall Street amid global economic concerns. Ironically, the news that's bolstering NVOS stock features some strong international overtones, with Novo entering a joint venture (JV) agreement with Canada's Farm 7 Group to implement the Kenya Agricultural Cooperative Project.

Why Is Novo Integrated Sciences (NVOS) Stock Up 60% Today?

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) today announced the Company and Farm 7 Group Inc., a Canada corporation (“F7”), have entered into a joint venture agreement (the “JV Agreement”) relating to the development, administration and arrangement of structured financing for the implementation and commencement of the Kenya Agricultural Cooperative Project (the “Kenya Agricultural Project”), a Kenya centric agricultural project with.

Novo Integrated Sciences and Farm 7 Group Announce Joint Venture for Kenya Cooperative Agricultural Project

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services and product innovation, today reported its financial results for the third fiscal quarter ended May 31, 2023. Robert Mattacchione, Novo's CEO and Board Chairman, stated, “The Company remains committed to the commercial.

Novo Integrated Sciences Reports Fiscal Year 2023 Third Quarter Financial Results

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Receives $40,000,000 Commitment to Develop Eldercare Facilities in Canada.

Novo Integrated Sciences Receives $40,000,000 Commitment to Develop Eldercare Facilities in Canada

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Reports Fiscal Year 2023 Second Quarter Financial Results.

Novo Integrated Sciences Reports Fiscal Year 2023 Second Quarter Financial Results

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Reports Fiscal Year 2023 First Quarter Financial Results.

News for Novo Integrated Sciences, Inc. Stock (NVOS)